COMMUNIQUÉS West-GlobeNewswire

-
Genocea to Present at September Healthcare Conferences
30/08/2019 -
Bhang Inc. Graduates to the OTCQX Best Market in U.S. and Announces OTC Ticker Symbol Change to “BHNGF”
30/08/2019 -
TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference
30/08/2019 -
Blueberries Medical Corp. Closes Over-Subscribed Private Placement
30/08/2019 -
Ambu A/S: Articles of Association
30/08/2019 -
Ambu A/S: Capital increase in connection with exercise of warrants issued
30/08/2019 -
Myriad Genetics to Present at the 2019 Morgan Stanley Global Healthcare Conference
30/08/2019 -
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)
30/08/2019 -
Lexicon Pharmaceuticals To Present At Upcoming Investor Conference
30/08/2019 -
Oncology Venture publishes Interim Report for the period January – June 2019
30/08/2019 -
Teleflex to Showcase its Peripheral Intervention Product Portfolio Highlighting the Arrow® OnControl® Powered Bone Access System and the MANTA™ Vascular Closure Device at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2019
30/08/2019 -
Coloplast: Announcement no. 09/2019 - Financial calendar 2019/20
30/08/2019 -
Media Advisory - Save Your Skin lance le premier défi « Move For Melanoma » au bénéfice des patients atteints de cancer de la peau au Canada
30/08/2019 -
Les résultats financiers d'Emerald Health Therapeutics au deuxième trimestre 2019 indiquent un doublement des ventes pour le deuxième trimestre consécutif
30/08/2019 -
Veta™ Smart Case & App for epinephrine auto-injectors (such as EPIPEN®) now available in Walgreens
30/08/2019 -
C-RAD AB – Interim report January-June 2019
30/08/2019 -
BBS Interim Report H1/2019
30/08/2019 -
Tania Micki to succeed long-time CFO Rudolf Eugster in Q1 2020 with effect from 2019 annual financial statements
30/08/2019 -
Ofatumumab Demonstrates Superiority Versus Teriflunomide in Two Head-to-Head Phase III Multiple Sclerosis Studies
30/08/2019
Pages